IMMUNIC, INC. - Common Stock (IMUX)

Historical Holders from Q2 2019 to Q1 2025

Symbol
IMUX on Nasdaq
CUSIP
4525EP101
Type / Class
Equity / Common Stock
Shares outstanding
89.6M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
51.1M
Holdings value
$51.1M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
65
Number of buys
29
Number of sells
-22
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of IMMUNIC, INC. - Common Stock (IMUX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Avidity Partners Management LP 9.9% $9.43M 9.02M Avidity Partners Management LP Dec 31, 2024
VANGUARD GROUP INC 4.35% $4.1M 3.92M The Vanguard Group Dec 31, 2024
JANUS HENDERSON GROUP PLC 3% $2.81M 2.69M JANUS HENDERSON GROUP PLC Dec 31, 2024
Adage Capital Management, L.P. 1.55% $1.46M 1.4M Adage Capital Management, L.P. Dec 31, 2024

Institutional Holders of IMMUNIC, INC. - Common Stock (IMUX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 30.9K $33.7K +$19.3K $1.09 5
2024 Q4 51.1M $51.1M -$5.07M $1.00 65
2024 Q3 56M $92.4M +$4.08M $1.65 61
2024 Q2 55.8M $62.1M -$1.86M $1.11 57
2024 Q1 57.4M $75.7M +$55.5M $1.32 60
2023 Q4 15.1M $22.6M -$4.81M $1.50 48
2023 Q3 18.3M $26.9M -$3.48M $1.47 52
2023 Q2 20.2M $50.7M -$8.73M $2.51 62
2023 Q1 24.7M $36.8M +$3.21M $1.49 56
2022 Q4 23.9M $33.4M +$4.48M $1.40 56
2022 Q3 17M $53.6M -$3.01M $3.16 58
2022 Q2 17.8M $61.6M -$12M $3.47 61
2022 Q1 17.6M $199M +$44.4M $11.30 77
2021 Q4 13.7M $131M +$7.6M $9.57 66
2021 Q3 12.9M $114M +$30.2M $8.85 66
2021 Q2 9.41M $115M -$1.38M $12.26 55
2021 Q1 9.3M $148M -$6.25M $15.94 58
2020 Q4 9.02M $138M +$13M $15.29 64
2020 Q3 8.55M $159M +$86.1M $18.57 63
2020 Q2 4.21M $51M +$24.9M $12.12 46
2020 Q1 2.12M $12.8M +$115K $6.01 14
2019 Q4 2.14M $20.7M +$6.19M $9.70 13
2019 Q3 1.5M $15M -$480K $10.00 17
2019 Q2 1.54M $17.6M +$17.6M $11.46 20